Back to Search

DOUG FRYE, M.D.

M.D.

Physical Medicine & Rehabilitation Physician

NPI: 1780647495IndividualAccepts Medicare

Specialties, Licenses & Credentials

Physical Medicine & Rehabilitation PhysicianPrimary

Physical Medicine & Rehabilitation

Code: 208100000X

0422923(KS)

CMS Specialties

PrimaryPHYSICAL MEDICINE AND REHABILITATION

Additional

OSTEOPATHIC MANIPULATIVE MEDICINE

Education

UNIVERSITY OF COLORADO SCHOOL OF MEDICINE, DENVER

Class of 1982

Research & Publications (20)

Neonatal and maternal outcomes associated with elective term delivery.
PMID 19110225·Am J Obstet Gynecol·2009
4-observational
Capecitabine-based combination therapy for breast cancer: implications for nurses.
PMID 19136344·Oncol Nurs Forum·2009
6-review
Phase I study of prolonged-infusion gemcitabine combined with cyclophosphamide in patients with metastatic carcinoma of the breast: tolerability of an optimal dose schedule.
PMID 19556811·Oncology·2009
3-trial
HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancer.
PMID 17468948·Breast Cancer Res Treat·2008
8-other
Using response to primary chemotherapy to select postoperative therapy: long-term results from a prospective phase II trial in locally advanced primary breast cancer.
PMID 19073507·Clin Breast Cancer·2008
3-trial
Demographic characteristics and sexual behaviors associated with methamphetamine use among MSM and non-MSM diagnosed with AIDS in Los Angeles County.
PMID 17968649·AIDS Behav·2008
8-other
Phase II trial of 10-EDAM in the treatment of metastatic breast cancer.
PMID 17009032·Cancer Chemother Pharmacol·2007
3-trial
Implementation of a conservative checklist-based protocol for oxytocin administration: maternal and newborn outcomes.
PMID 17980181·Am J Obstet Gynecol·2007
8-other
Increases in noninjection methamphetamine use in men who have sex with men, men who do not have sex with men, and Latino men diagnosed with AIDS in Los Angeles County, 2000 through 2004.
PMID 17704687·J Acquir Immune Defic Syndr·2007
8-other
Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers.
PMID 17293601·Ann Oncol·2007
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
5000 SW 21ST ST
TOPEKA, KS 66604

Quick Facts

NPI
1780647495
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
44
Publications
20

Are you this provider?

Claim Your Profile